Coffee offers numerous health benefits when consumed in moderation—up to four cups per day. Recent research from the Krembil Brain Institute in Ontario, Canada, suggests it may slow aging, extend lifespan, and lower the risk of Alzheimer's and Parkinson's diseases. Scientists examined three varieties of Starbucks' 100% Arabica coffee: light roast, dark roast, and decaffeinated dark roast. They identified phenylindane, a compound formed during roasting that contributes to coffee's bitter taste. Crucially, phenylindane inhibits the buildup of beta-amyloid and tau proteins, which are hallmarks of Alzheimer's and Parkinson's in the brain.
"This marks the first study to explore phenylindanes' interactions with proteins linked to Alzheimer's and Parkinson's degenerative processes. Next, we'll assess the extent of these benefits and whether these compounds can enter the bloodstream and cross the blood-brain barrier," says Dr. Ross Mancini, a key researcher. Co-director Dr. Donald Weaver emphasizes nature's role: "Mother Nature is a superior chemist. This research refines epidemiological data, confirming coffee contains compounds that slow cognitive deterioration." Dark roast proved most effective against these diseases. However, Dr. Weaver stresses: "These findings are promising, but coffee is not a cure."
